相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Soluble ST2 in heart failure
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2015)
Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
Antonio Lax et al.
JACC-HEART FAILURE (2015)
IL-33-Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo
David J. Jackson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Tumor Necrosis Factor-α Accelerates the Resolution of Established Pulmonary Fibrosis in Mice by Targeting Profibrotic Lung Macrophages
Elizabeth F. Redente et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension
Dongmin Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects
Amal Hasan et al.
BMC IMMUNOLOGY (2014)
Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33
A. M. Shadie et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers
Jesus Sanchez-Mas et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Fibrosis and heart failure
Ana Maria Segura et al.
HEART FAILURE REVIEWS (2014)
Emerging role of interleukin-33 in autoimmune diseases
Cheng Pei et al.
IMMUNOLOGY (2014)
Transforming growth factor β3 attenuates the development of radiation-induced pulmonary fibrosis in mice by decreasing fibrocyte recruitment and regulating IFN-γ/IL-4 balance
Long Xu et al.
IMMUNOLOGY LETTERS (2014)
Association of Interleukin 1 Family with Systemic Sclerosis
Li Zhang et al.
INFLAMMATION (2014)
The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy
Taichiro Muto et al.
INTERNATIONAL IMMUNOLOGY (2014)
The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1,-4 and-5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase and phosphoinositide 3-kinase signaling pathways
Tim G. Ashlin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis
Barbara Berschneider et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis
Nanzheng Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
Dong Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation
Jun Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-131 dependent and independent mechanisms (vol 187, pg 3003, 2011)
S. Mi et al.
JOURNAL OF IMMUNOLOGY (2014)
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Thanh-Thuy T. Le et al.
JOURNAL OF IMMUNOLOGY (2014)
Head- to- Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
E. Krafft et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
H. J. McSorley et al.
MUCOSAL IMMUNOLOGY (2014)
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Kuan-Min Fang et al.
NEURO-ONCOLOGY (2014)
Pigment Epithelium-Derived Factor 34-mer Peptide Prevents Liver Fibrosis and Hepatic Stellate Cell Activation through Down-Regulation of the PDGF Receptor
Tung-Han Tsai et al.
PLOS ONE (2014)
Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells
Stefanos Klironomos et al.
REGULATORY PEPTIDES (2014)
DNA methylation in cardiac fibrosis: New advances and perspectives
Hui Tao et al.
TOXICOLOGY (2014)
Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice
Ying Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Innate-Type and Acquired-Type Allergy Regulated by IL-33
Tomohiro Yoshimoto et al.
ALLERGOLOGY INTERNATIONAL (2014)
Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
Chang-Min Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Using ST2 in cardiovascular patients: a review
Lori B. Daniels et al.
FUTURE CARDIOLOGY (2014)
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Lutz Wollin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Interleukin-33 Potentiates Bleomycin-Induced Lung Injury
Irina G. Luzina et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Renal epithelial injury and fibrosis
Brigitte Kaissling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The Role of Interleukin-33 in Rhinitis
Barbara Rogala et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis
Cathal McCarthy et al.
FASEB JOURNAL (2013)
IL-33 in rheumatoid arthritis: Potential role in pathogenesis and therapy
Wang-Dong Xu et al.
HUMAN IMMUNOLOGY (2013)
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Tamar Mchedlidze et al.
IMMUNITY (2013)
Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice
A. E. Jaaskelainen et al.
NEUROPEPTIDES (2013)
被撤回的出版物: Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion (Retracted article. See vol. 14, 2019)
Lance D. Presser et al.
PLOS ONE (2013)
Effects of interleukin-33 on cardiac fibroblast gene expression and activity
Jinyu Zhu et al.
CYTOKINE (2012)
Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype
Larissa Cardilo-Reis et al.
EMBO MOLECULAR MEDICINE (2012)
IL-33/ST2 axis in inflammation and immunopathology
Marija Milovanovic et al.
IMMUNOLOGIC RESEARCH (2012)
IL-33 regulates TNF-α dependent effects in synovial fibroblasts
Elke Kunisch et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway
Chia-Lin Hsu et al.
JOURNAL OF IMMUNOLOGY (2012)
Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion
Irina G. Luzina et al.
JOURNAL OF IMMUNOLOGY (2012)
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Isis E. Fernandez et al.
LANCET (2012)
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
Frank L. van de Veerdonk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches
Elisabetta Mormone et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
Koichi Yanaba et al.
CLINICAL RHEUMATOLOGY (2011)
Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-β1-Dependent and -Independent Mechanisms
Su Mi et al.
JOURNAL OF IMMUNOLOGY (2011)
The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB-Stimulated Gene Transcription
Shafaqat Ali et al.
JOURNAL OF IMMUNOLOGY (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Interleukin-33 biology with potential insights into human diseases
Gaby Palmer et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
Jon Sponheim et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Nuclear expression of interleukin-33 in pancreatic stellate cells
Atsushi Masamune et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Adaptive T cell immune responses and atherogenesis
Soraya Taleb et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts
Atsushi Nishida et al.
GUT (2010)
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
Pierrick Marvie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
IL-33 Induces IL-13-Dependent Cutaneous Fibrosis
Andrew L. Rankin et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-33 Reduces Macrophage Foam Cell Formation
James E. McLaren et al.
JOURNAL OF IMMUNOLOGY (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
I. Stuart Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
The Essential Role of Single Ig IL-1 Molecule/Toll IL-1R8 in Regulation Immune Response
Katarzyna Bulek et al.
JOURNAL OF IMMUNOLOGY (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization
Cecilia Garlanda et al.
TRENDS IN IMMUNOLOGY (2009)
Active caspase-1 is a regulator of unconventional protein secretion
Martin Keller et al.
CELL (2008)
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33
Gaby Palmer et al.
CYTOKINE (2008)
Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket
Lucie Roussel et al.
EMBO REPORTS (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis
Maritta Sampi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Shafiq U. Rehman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
Shafaqat Ali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation
Hiroko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
Alissa A. Chackerian et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis
Adi Mor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis
Shunji Tajima et al.
EXPERIMENTAL LUNG RESEARCH (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis
AD Hauer et al.
CIRCULATION (2005)
IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells
C Tenger et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen
YP Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
CJ Binder et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis
E Borkham-Kamphorst et al.
LABORATORY INVESTIGATION (2004)
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C
A Bonacchi et al.
GASTROENTEROLOGY (2003)
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice
P Davenport et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules
ES Baekkevold et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)
Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V
K Tago et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
分享论文
